Relapsed/Refractory B-cell ALL
2 clinical trials · Condition
◉ Watch Relapsed/Refractory B-cell ALL
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms (NCT07234045) | Institute of Hematology & Blood Diseases Hospital, China | 2025-11-30 |
| CART-19 Cells For R/R B-ALL (NCT03391739) | Fujian Medical University | 2016-01-01 |
Track Relapsed/Refractory B-cell ALL automatically
Every clearance here is in the API, with alerts when new ones post.